TITLE

Test for GERD Reveals That Many Are Taking Medications Unnecessarily

PUB. DATE
September 2013
SOURCE
Women's Health Advisor;Sep2013, Vol. 17 Issue 9, p5
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the increased inappropriate use of proton pump inhibitors (PPI) by people without being diagnosed with gastro esophageal reflux disease (GERD). It suggests for early diagnosis of GERD by esophageal power of hydrogen (Ph) monitoring following an endoscopy which helps to evaluate the patients for alternative diagnoses to GERD like peptic ulcer disease or malignancy. It discusses the side effects of PPI including osteoporosis, hypomagnesemia and bone fractures in women.
ACCESSION #
89800898

 

Related Articles

  • Pharmacokinetic drug interaction profile of omeprazole with adverse consequencesand clinical risk management. Wei Li; Su Zeng; Lu-Shan Yu; Quan Zhou // Therapeutics & Clinical Risk Management;2013, Vol. 9, p259 

    Background: Omeprazole, a proton pump inhibitor (PPI), is widely used for the treatment of dyspepsia, peptic ulcer, gastroesophageal reflux disease, and functional dyspepsia. Polypharmacy is common in patients receiving omeprazole. Drug toxicity and treatment failure resulting from inappropriate...

  • Effects of proton pump inhibitors on gastric emptying: a systematic review. Sanaka, Masaki; Yamamoto, Takatsugu; Kuyama, Yasushi // Digestive Diseases & Sciences;Sep2010, Vol. 55 Issue 9, p2431 

    The proton pump inhibitor (PPI) is widely used for the treatment of gastroesophageal reflux disease, peptic ulcer diseases, and functional dyspepsia. The pathogenesis of these acid-related and/or functional upper gastrointestinal disorders is potentially associated with abnormal gastric...

  • Proton Pump Inhibitors in Pediatrics. Ward, Robert; Kearns, Gregory // Pediatric Drugs;2013, Vol. 15 Issue 2, p119 

    Proton pump inhibitors (PPIs) have become some of the most frequently prescribed medications for treatment of adults and children. Their effectiveness for treatment of peptic conditions in the pediatric population, including gastric ulcers, gastroesophageal reflux disease (GERD), and...

  • Proton Pump Inhibitors After Endoscopic Hemostasis in Patients With Peptic Ulcer Bleeding. Mesihovic, Rusmir; Vanis, Nenad; Mehmedovic, Amila; Gornjakovic, Srdjan; Gribajcevic, Mehmed // Medicinski Arhiv;2009, Vol. 63 Issue 6, p323 

    Background: Peptic ulcer bleeding is a common and potentially fatal condition. For patients with bleeding peptic ulcers that display major endoscopic stigmata of recent hemorrhage, a combination of endoscopic and pharmacologic therapy is the current standard management. Objective: To show our...

  • Continuous Infusion of Pantoprazole versus Ranitidine for Prevention of Ulcer Rebleeding: A U.S. Multicenter Randomized, Double-Blind Study. Jensen, Dennis M.; Pace, Samuel C.; Soffer, Elaine; Comer, Gail M. // American Journal of Gastroenterology;Sep2006, Vol. 101 Issue 9, p1991 

    OBJECTIVES: No North American randomized study has compared ulcer rebleeding rates after endoscopic hemostasis in high-risk patients treated with high-dose intravenous (IV) proton pump inhibitors (PPIs) or IV histamine-2 receptor antagonists. Our hypothesis was that ulcer rebleeding with IV...

  • Esophagitis in a High H. pylori Prevalence Area: Severe Disease Is Rare but Concomitant Peptic Ulcer Is Frequent. Ponce, Julio; Calvet, Xavier; Gallach, Marta; Ponce, Marta // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    Background: Few data are available on the prevalence of erosive and severe esophagitis in Western countries. Objective: To retrospectively determine the prevalence and the factors predicting erosive esophagitis and severe esophagitis in a large series of endoscopies in Spain. Design:...

  • Esophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy. Shaheen, Nicholas J; Denison, Hans; Björck, Karin; Silberg, Debra G // American Journal of Gastroenterology;Apr2013, Vol. 108 Issue 4, p529 

    OBJECTIVES:Approximately 20-30% of patients with gastroesophageal reflux disease (GERD) do not experience complete symptom resolution during proton pump inhibitor (PPI) therapy. The aim of this study was to determine the prevalence of esophageal mucosal breaks among patients who have a partial...

  • Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Witteman, Bart; Strijkers, Rob; Vries, Eva; Toemen, Liza; Conchillo, José; Hameeteman, Wim; Dagnelie, Pieter; Koek, Ger; Bouvy, Nicole // Surgical Endoscopy;Nov2012, Vol. 26 Issue 11, p3307 

    Background: Transoral incisionless fundoplication is a recently introduced endoluminal technique for the treatment of gastroesophageal reflux disease (GERD). The objective of this study was to determine outcomes in chronic GERD patients who were referred for surgical management. Methods: A...

  • Management of Asymptomatic Erosive Esophagitis: An E-Mail Survey of Physician's Opinions. Seong Woo Lim; Jun Haeng Lee; Jie-Hyun Kim; Jeong Hwan Kim; Heung Up Kim; Seong Woo Jeon // Gut & Liver;May2013, Vol. 7 Issue 3, p290 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics